P/E ratio for Aytu BioScience (AYTU)
P/E ratio as of April 2024 (TTM): -0.2828
According to Aytu BioScience 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.282795. At the end of 2022 the company had a P/E ratio of -0.0711.
P/E ratio history for Aytu BioScience from 2008 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.0711 | 28.59% |
| 2021 | -0.0553 | -97.35% |
| 2020 | -2.08 | 256.28% |
| 2019 | -0.5848 | 427.49% |
| 2018 | -0.1109 | -34.53% |
| 2017 | -0.1693 | 36.77% |
| 2016 | -0.1238 | |
| 2014 | -314 | -48.3% |
| 2013 | -607 | -44.53% |
| 2012 | < -1000 | 386.24% |
| 2011 | -225 | 22.97% |
| 2010 | -183 | -65.13% |
| 2009 | -525 | 11.96% |
| 2008 | -469 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Rollins ROL | 54.1 | -19,229.19% | 🇺🇸 USA |
 Stride (K12 Education)
LRN | 18.4 | -6,616.59% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.